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Summary: A continuous procedure for the determination of leucine aminopeptidase is described.
L-leucinamide is used äs Substrate and the liberated ammonia is determined with the glutamate dehydrogenase
reaction. The enzyme is Mn2+-activated and 30 / MnCl2 is necessary for an optimal activity measurement.
Influence of buffer type, buffer concentration and pH are reported together with the apparent Km values of
leucine aminopeptidase for L-leucinamide and of glutamate dehydrogenase for 2-oxoglutarate. Amastatin, a
potent inhibitor, iiihibits the reaction of leucine aminopeptidase completely, whereas it has no inhibitory
effect on the reaction with glutamate dehydrogenase. The normal reference interval for leucine aminopeptidase
is 12 — 65 U/l at 37 °C. The properties of the enzyme are discussed.
Eine kontinuierliche Methode zur Bestimmung von Leucinaminopeptidase in menschlichem Serum
Zusammenfassung: Es wurde ein kontinuierliches Verfahren zur Bestimmung von Leucinaminopeptidase mit
L-Leucinamid als Substrat untersucht. Das freigesetzte Ammoniak wird mit der Glutamatdehydrogenase-
Reaktion bestimmt. Das Enzym wird aktiviert von Mn2+ und 30 / von MnCl2 ist für eine optimale
Aktivität erforderlich. Der Einfluß von Art des Puffer, Pufferkonzentration und pH wird zusammen mit dem
scheinbaren #m-Wert von Leucinaminopeptidase für L-Leucinamid und von Glutamatdehydrogenase für 2-
Oxoglutarat beschrieben. Amastatin hemmt Leucinaminopeptidase vollständig, während es keine hemmende
Wirkung auf die Glütamatdehydrogenase-Reaktion hat. Der Referenzbereich beträgt 12—65 U/l bei 37 °C.
Die Eigenschaften des Enzyms werden diskutiert.
Introduction formed from L-leucinämide after hydrolysis is deter-
Leucine aminopeptidase (ot-aminoacyl-peptide mined by paper chromatography (5) or the liberated
hydrolase (cytosol); EC 3.4.114) is a zinc-metallö- ammonia is rneasured according to Berthelot (6, 7) or
enzyme, which oceurs in tissues and body fluids of by titration (8). Unti'l now no continuous monitoring
all organisms. It was first cryställized from bovine procedure for the determination of leucine amino-
lens (1) and afterwards purified from hog kidney (2), peptidase in serum has been described, except for
swine kidney (3) and human liver (4). a method using leucine dehydrogenase (L-leucine:
„,, * , · * - i * · NAD+ oxidoreductase (deaminating) EC 1.4.1.9) äs
The enzyme is able to hydrolyse ^pepüdes releasing indicator me (9)
a single amino acid from the N-terminus of the pep-
tide chain. L-Leucinamide is a suitable Substrate for In the present paper a continuous method is reported,
the enzyme. Different methods for the determination in which the ammonia liberated after hydrolysis of L-
of the catalytic activity concentration of leucine leucinamide by leucine aminopeptidase is determined
aminopeptidase have been described. The leucine according to the following reaction scheme:
J. Clin. Chem. Clin. Biochem. / VoL 23,1985 / No. 7
394 Haflcenscheid and Kohler: Determination of leucine aminopeptidase with L-leucinamide s Substrate
L-leucinamide ?^ L-leucine + NH3
2-oxoglutarate + NH3 + NADPH + H+ —> L-glutamate +
NADP+
The equilibrium of the indicator reaction with gluta-
mate dehydrogenase (L-glutamate: NAD(P)+
oxidoreductase (deaminating) EC 1.4.1.3) lies far to
the right, so that changes in absorbance at 340 nm
are directly proportional to the concentration of am-
monia. The principle of this reaction has been de-
scribed previously (10 — 12).
The results of our study leading to the development
of a continuous procedure for the determination of
leucine aminopeptidase are presented.
Materials and Methods
All determinations were carried out at 37 °C on a Multistat III
microcentrifugal analyser (Instrumentation Laboratory,
Usselstein, The Netherlands). The final reaction mixture for
leucine aminopeptidase contained per liter: triethanolamine
(pH 8.2) 90 mmol, MnCl2 30 μπιοί, 2-oxoglutarate 14.3 mmol,
NADPH 300 μηιοί, ADP 1.4 mmol, glutamate dehydrogenase
0.047 g and L-leucinamide 100 mmol. Sample (6 μΐ) was added
to 93 μΐ of reaction mixture containing triethanolamine, MnCl2,
2-oxoglutarate, NADPH, ADP and glutamate dehydrogenase.
After standing at room temperature for 10 min the rotor was
placed in the analyser. The preincubation time at 37 °C was 10
min. After starting the reaction with 63 μΐ of L-leucinamide the
decrease in absorbance was read every 30 s from 2 min until 5
min after the beginning of the reaction.
In testing the different parameters all other conditions for the
reaction rate determinations were held constant.
Blood was taken by venipuncture and promptly centrifuged:
the sera were stored at 4 °C and assayed s soon s possible.
All catalytic activity concentrations are expressed in U/l.
L-Leucinamide and amastatin were purchased from Sigma,
Brunschwig, Amsterdam, The Netherlands, and glutamate de-
hydrogenase from beef liver (100 mg/10 ml) from Boehringer,
Mannheim, FRG. All other Chemicals were reagent grade.
In the statistical analysis we used Studenfs t-test for paired
observations.
Results and Discussion
Figure l shows the time dependence of the enzymatic
reaction. A linear relationship was observed up to
5 min after starting the reaction with L-leucinamide.
Reagent blank and sample blank are also given and
these are always subtracted from the determination
before the catalytic activity concentrations are cal-
culated.
Figure l shows also the reaction rate s a function
of the amount of sample added. The reaction is linear
up to 500 U/l and samples with higher activities have
to be diluted with saline. Table l shows the effect o f «
various bivalent cations on the catalytic activity. It
is obvious that addition of Mn2+ions increases the
activity concentration by about 17%, whereas the
addition of Mg2+ and Fe2+ions showed only a very
small effect. Zn2+ions inhibit the activity con-
centration very slightly. Co2+ions have a stimulatory
effect on the glutamate dehydrogenase activity (own
observation), so the effect of'Co2"1" on the leucine
aminopeptidase activity could not be determined.
Preincubation of serum with Mn2+ in the presence
of all other reagents except L-leucinamide g ve a
catalytic activity concentration that was 10% higher
than that obtained by incubation of serum with Mn2+
alone (129.0 ± 62.8 U/l and 118.1 + 69.3 U/l re-
spectively; n = 17; p < 0.05). Therefore we pre-
incubated the serum with Mn?+ions in the total re-
agent mixture without L-leucinamide in all our de-
terminations.
In figure 2 the effect of various concentrations of
Mn2+ on the determination of leucine amino-
peptidase is given. From 25 μπιοΙ/1 to 100 μπιοΐ/ΐ Μη2"1"
ions no further increase of the catalytie activity was
observed. We chose a concentration of 30 μηαοΐ/ΐ
Mn?H~ions in our Standard procedure.
Table 2 shows the effect of different buffers on the
catalytic activity concentratiori of leucine
aminopeptidase. The highest activity concentration
was obtained with trietha.nolamine, which was there-
fore chosen s the assay buffer. In comparison, for
example, borate buffer gives only 60% of the activity
concentration observed in triethanolamine. Figure 3
shows the dependency of the catalytic activity con-
centration on the ioriic strength of the buffer
triethanolamine. The catalytic activity did not change
significantly when the buffer concentration was
varied between about 80 and 300 mmol/1. We chose a
concentration f 90 mmol/1 triethanolamine.
The pH dependency of the catalytic activity of leucine
aminopeptidase is given in figure 4. The highest activ-
ity concentration was obtained at pH 8.2 in a buffer
System of 90 mmol/1 triethanolamine. It is obvious
that at this pH the combination of both enzymes,
leucine aminopeptidase and glutamate dehy-
drogenase, gives the highest activity concentration.
Therefore, no comparison caii be made with the pH
Optimum of leucine aminopeptidase from serum (6)
or from human liver (4). Figure 5 shows the relation
between v and v/[S] for le eine aminopeptidase, when
the concentration of the Substrate« L-le cin mide is
varied. The mean apparent Km value obtained from
the slope of this line is 6,60 ± 1.27 rnmol/1 for 6
determinations in comparison with K^ values
obtained for two different leucine aminopeptidase
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Fig. 1. Left: Time dependence of leucine aminopeptidase determination in serum.
o o sample blank
χ \ and o— —o 2 sera.
Right: Reaction rate s a function of the amount of sam
4 determinations).
Tab. 1 . Effect of various cations on the catalytic activity con-
centration of leucine aminopeptidase (n = 14). Fe2+
and Zn2+ were added s sulphates, other ions s Chlor-
ides. All differences are significant (p < 0.05) except
between 1 and 2.
Ions added Catalytic concentration
;, (30 μπιοΐ/l) (U/l)
188.3 + 64.1
Mg2+ 191.8 + 65.1
! Fe2+ 194.1 + 65.5
Zn2+ 179.9 + 63.3
Mn2+ 220.6 ± 82.8
>·»
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Fig. 2. Influence of Mn2+ on the determination of leucine
aminopeptidase in serum. (Mean of'5 determinations).
Tab. 2. Effect of various buffer Systems on the leucine amino-
peptidase determination in serum (n = 7). All
differences are significant (p < 0.05).
Buffer Catalytic concentration
(150 mmol/l) (U/l)
Triethanolamine 73.6 ± 29.1
Tris 64.1 + 24.6
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Dependence of the catalytic activity of leucine amino-
jeptidase on the concentration of the buffer
riethanolamine. (Mean of 8 determinations.)
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Fig. 4. Effect of pH on the leucine aminopeptidase activity of
serum. (Mean of 5 determinations.)
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Fig. 5. Reactipn rate of leucine aminopeptidase s a function
of the concentration of L-leucinamide. (Mean of 6 de-
terminations.)
fractions from pig kidney of 5.21 and 15.7 mimol/1
(13) or from human liver of 7.7 or 10.5 mmol/1 (4).
In all our experiments we used a final Substrate con-
centration of 100 mmol/1 (approximately 15-times the
apparent Km value) which resulted in a zero-order
rate reaction.
The effect of Variation of the concentration of
NADPH is given in figure 6. It is obvious that no
catalytic activity can be measured at concentrations
of NADPH less than 50 μιηοΐ/ΐ. We added 300 μπιοΐ/ΐ
NADPH to the Standard reaction mixture.
ADP is necessary for stabilisation of the indicator
enzyme glutamate dehydrogenase and increases the
rate of conversion of NH3 considerably (11). We
added always l .4 mmol/1 ADP to the reaction mixture,
which is sufficient for optimal reaction rates (fig. 7).
The influence of increasing amounts of 2-
oxoglutarate on the reaction rate is given in figure 8.
The apparent Km value of glutamate dehydrogenase
for 2-oxoglutarate can be calculated from the slope
of this line. The choice of 14.3 mmol/1 of 2-
oxoglutarate in the final reaction mixture ensures
adequate Substrate Saturation at more than 10 times
the apparent K^ value of 0.52 ± 0.05 mmol/1. This
value agrees with the apparent Km value of 0.7 mmol/1
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Fig. 6. Reactipn rate of leucine aminopeptidase s a function












ADP [ m m o l / l ]
Fig. 7. Effect of addition of ADP on the catalytic activity
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Fig. 8. Reaction rate of leucine aminopeptidase s a function
of the concentration of 2-oxoglutarate. (Mean of 7
determinations.)
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The influence of the addition of glutamate de-
hydrogenase to the reaction mixture is given in figure
9. Increasing amounts of glutamate dehydrogenase
enhance the reaction rate of leucine aminopeptidase.
We chose 47 mg/1 glutamate dehydrogenase, which is
sufficient for an optimal reaction rate.
The dependence of the measured catalytic activity
concentration of leucine aminopeptidase on the re-
lation between sample and total assay volume is seen
in figure 10. There is an increase of the catalytic
activity concentration up to a volume fraction of
0.03, and a decrease at higher volume fractions. For
practical reasons we chose a volume fraction of sam-
ple of 0.037, which is about 2% lower than that
required for maximal catalytic activity concentration.
The within-day and between-day variabilites are
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Fig. 9. Influence of the addition of glutamate dehydrogenase
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Fig. 10. Relationship 'between the catalytic concentration of
leucine aminopeptidase and the volume fraction of
sample. (Mean of 4 determinations.)






















We carried out all our determinations at 37 °C. The
temperature converting factor from 37 °C to 30 °C
was 0.614 ± 0.068 for 55 determinations.
Amastatin is a well known inhibitor of leucine
aminopeptidase because it binds to cell surfaces and
therefore inhibits cell-surface aminopeptidases (15).
Addition of 25 μπιοΐ/ΐ of amastatin to the reaction
mixture inhibits the enzyme completely. Amastatin
has no inhibitory effect on the glutamate de-
hydrogenase reaction; (30.2 + 11.3 μιηοΐ/l NH3 in the
absence of amastatin and 33.6 + 7.0 μπιοΙ/1 in its
presence; n = 5; p > 0.40).
Leucine aminopeptidase activity concentrations were
determined in sera from 144 healthy people. The
normal reference interval (mean + 2 S.D.) was
12-65U/lat37°C.
Based on the determination of ammonia described
by da Fonseca-Wollheim (10,11), a continuously mon-
itoring procedure has thus been designed for the
determination of leucine aminopeptidase. Most of the
Parameters of this method are related to the proper-
ties of glutamate dehydrogenase, the indicator en-
zyme of the reaction scheine. But these parameters
are also compatible with the measurement of the
catalytic activity concentration of leucine amino-
peptidase by this method.
It is difficult to distinguish leucine aminopeptidase
from amino acid arylamidase (ot-aminoacyl-peptide
hydrolase (microsomal) EC 3.4.11.2), although the
first enzyme occurs in the cytosol of the cells and the
second one is microsomal. These two enzymes show
different Substrate specificities. Leucine amino-
peptidase hydrolyses leucine-peptides s well s L-
leucinamide, while amino acid arylamidase splits
preferentially alanine from peptides, amides and 4-
nitroanilides; but this Substrate specificity is not
absolute. From studies by N H be & Fujii (16) it is
obvious that an enzyme preparation of leucine amino-
peptidase purified from human liver is able to split
L-alanyl- -naphthylamide and a purified enzyme pre-
paration of amino acid arylamidase hydrolyses L-
J. Clin. Chem. Clin. Biochem. / Vol. 23,1985 / No. 7
398 Hafkenscheid and Kohler: Determination of leucine aminopeptidase with L-leucinamide äs Substrate
leucinamide. Generally it is accepted that L-
leucinamide is the preferred Substrate for leucine
aminopeptidase originating from tissues or serum.
Plaquet et al. (6) described in normal and pathological
human sera two enzymes, which are able to split L-
leucinamide. The "alkaline enzyme" has a pH
optimum of 9.0 and is activated by Mg2+ions, while
the second enzyme ("neutral enzyme"), has an
optimal activity at pH 7.8 and is inhibited by Mg2+
ions. The reference value for the "alkaline enzyme"
is l .2 U/l at 37 °C. A comparison between the proper-
ties of the enzymes described by us and by Plaquet
et al. (6) is difficult, because we determined the kinetic
properties of leucine aminopeptidase in relation to
the properties of the indicator enzyme glutamate de-
hydrogenase. It seems that the enzymes are distinct,
since our enzyme is Mn2+ activated and the reference
value is much higher. f
The clinical value of the leucine aminopeptidase is
not exactly kiiowri. The relation between leucine
aminopeptidase and amino acid arylamidase is now
uiider investigation.
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